AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christoforidis, G. A.
Right arrow Articles by Mehta, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christoforidis, G. A.
Right arrow Articles by Mehta, B. M.

ARTICLE

MR of CNS Sarcoidosis: Correlation of Imaging Features to Clinical Symptoms and Response to Treatment

Greg A. Christoforidis,a, Eric M. Spicklera, Maria V. Recioa and Bharat M. Mehtaa

a From the Department of Radiology, Ohio State University Medical Center (G.A.C.), Columbus; and the Departments of Radiology (E.M.S., B.M.M.) and Ophthalmology (M.V.R.), Henry Ford Hospital, Detroit.

BACKGROUND AND PURPOSE: Sarcoidosis is an idiopathic systemic granulomatous disease, recognized in a patient when clinical and radiologic findings are confirmed by histopathologic analysis. The objective was to identify a relationship between MR imaging and clinical findings in CNS sarcoidosis.

METHODS: The clinical charts of 461 patients with biopsy-proved sarcoidosis were reviewed retrospectively. Criteria for including patients in the study included those with symptoms referable to the CNS, excluding those with another explanation for their symptoms, those with headaches or other subjective complaints without accompanying objective findings, and those with peripheral neuropathy other than cranial nerve involvement or myopathy without CNS manifestations. Thirty-four of 38 patients whose conditions met the criteria for CNS sarcoidosis underwent a total of 82 MR examinations. The positive imaging findings were divided into categories as follows: pachymeningeal, leptomeningeal, nonenhancing brain parenchymal, enhancing brain parenchymal, cranial nerve, and spinal cord and nerve root involvement. Treatment response, clinical symptomatology, and any available histopathologic studies were analyzed with respect to imaging manifestations in each of the categories.

RESULTS: Eighty-two percent of the patients with sarcoidosis with neurologic symptoms referable to the CNS had findings revealed by MR imaging. However, eight (40%) of 20 cranial nerve deficits seen at clinical examination of 13 patients were not seen at contrast-enhanced MR imaging, and 50% of the patients with symptoms referable to the pituitary axis had no abnormal findings on routine contrast-enhanced MR images. In contradistinction, 44% of 18 cranial nerves in nine patients with MR evidence of involvement had no symptoms referable to the involved cranial nerve. Clinical and radiologic deterioration occurred more commonly with leptomeningeal and enhancing brain parenchymal lesions.

CONCLUSION: MR imaging can be used to confirm clinical suspicion and to show subclinical disease and the response of pathologic lesions to treatment.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A. K Rudkin, R. A Wilcox, M. Slee, A. Kupa, and D. Thyagarajan
Relapsing encephalopathy with headache: an unusual presentation of isolated intracranial neurosarcoidosis
J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 770 - 771.
[Full Text] [PDF]


Home page
Br. J. Radiol.Home page
N Aide, M Benayoun, K Kerrou, A Khalil, J Cadranel, and J N Talbot
Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy
Br. J. Radiol., March 1, 2007; 80(951): e67 - e71.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M.H. Hodge, R.L. Williams, and M.B. Fukui
Neurosarcoidosis Presenting as Acute Infarction on Diffusion-Weighted MR Imaging: Summary of Radiologic Findings
AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 84 - 86.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
F. Saremi, M. Helmy, S. Farzin, C. S. Zee, and J. L. Go
MRI of Cranial Nerve Enhancement
Am. J. Roentgenol., December 1, 2005; 185(6): 1487 - 1497.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
J. A. Bourgeois, R. J. Maddock, L. Rogers, C. M. Greco, R. S. Mangrulkar, and S. Saint
Neurosarcoidosis and Delirium
Psychosomatics, April 1, 2005; 46(2): 148 - 150.
[Full Text] [PDF]


Home page
Arch NeurolHome page
F. Rodriguez, M. J. Link, C. L.W. Driscoll, and C. Giannini
Neurosarcoidosis Mimicking Meningioma
Arch Neurol, January 1, 2005; 62(1): 148 - 149.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. K. Smith, M. G. Matheus, and M. Castillo
Imaging Manifestations of Neurosarcoidosis
Am. J. Roentgenol., February 1, 2004; 182(2): 289 - 295.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A. Campi, G. Benndorf, V. Martinelli, M. R. Terreni, and G. Scotti
Spinal Cord Involvement in Primary Angiitis of the Central Nervous System: A Report of Two Cases
AJNR Am. J. Neuroradiol., March 1, 2001; 22(3): 577 - 582.
[Abstract] [Full Text]